BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30193815)

  • 1. Enhanced chemo-immunotherapy against melanoma by inhibition of cholesterol esterification in CD8
    Li M; Yang Y; Wei J; Cun X; Lu Z; Qiu Y; Zhang Z; He Q
    Nanomedicine; 2018 Nov; 14(8):2541-2550. PubMed ID: 30193815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy.
    Li M; Yang Y; Xu C; Wei J; Liu Y; Cun X; Yu Q; Tang X; Yin S; Zhang Z; He Q
    AAPS J; 2019 Jan; 21(2):18. PubMed ID: 30635795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism.
    Yang W; Bai Y; Xiong Y; Zhang J; Chen S; Zheng X; Meng X; Li L; Wang J; Xu C; Yan C; Wang L; Chang CC; Chang TY; Zhang T; Zhou P; Song BL; Liu W; Sun SC; Liu X; Li BL; Xu C
    Nature; 2016 Mar; 531(7596):651-5. PubMed ID: 26982734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
    Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
    J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-33 pretreatment promotes metastatic growth of murine melanoma by reducing the cytotoxic capacity of CD8
    Jevtovic A; Pantic J; Jovanovic I; Milovanovic M; Stanojevic I; Vojvodic D; Arsenijevic N; Lukic ML; Radosavljevic GD
    Cancer Immunol Immunother; 2020 Aug; 69(8):1461-1475. PubMed ID: 32285171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avasimibe encapsulated in human serum albumin blocks cholesterol esterification for selective cancer treatment.
    Lee SS; Li J; Tai JN; Ratliff TL; Park K; Cheng JX
    ACS Nano; 2015 Mar; 9(3):2420-32. PubMed ID: 25662106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A New Concept of Enhancing Immuno-Chemotherapeutic Effects Against B16F10 Tumor
    Yang Y; Tai X; Shi K; Ruan S; Qiu Y; Zhang Z; Xiang B; He Q
    Theranostics; 2016; 6(12):2141-2160. PubMed ID: 27698946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes.
    Gehrmann U; Hiltbrunner S; Georgoudaki AM; Karlsson MC; Näslund TI; Gabrielsson S
    Cancer Res; 2013 Jul; 73(13):3865-76. PubMed ID: 23658368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
    Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
    Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
    Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
    Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator.
    Pan J; Zhang Q; Palen K; Wang L; Qiao L; Johnson B; Sei S; Shoemaker RH; Lubet RA; Wang Y; You M
    EBioMedicine; 2019 Nov; 49():72-81. PubMed ID: 31680003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer.
    Celus W; Oliveira AI; Rivis S; Van Acker HH; Landeloos E; Serneels J; Cafarello ST; Van Herck Y; Mastrantonio R; Köhler A; Garg AD; Flamand V; Tamagnone L; Marine JC; Di Matteo M; Costa BM; Bechter O; Mazzone M
    Cancer Immunol Res; 2022 Jan; 10(1):126-141. PubMed ID: 34815265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation.
    Li SY; Liu Y; Xu CF; Shen S; Sun R; Du XJ; Xia JX; Zhu YH; Wang J
    J Control Release; 2016 Jun; 231():17-28. PubMed ID: 26829099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Artificial Antigen-Presenting Cell Delivering 11 Immune Molecules Expands Tumor Antigen-Specific CTLs in
    Zhang L; Song S; Jin X; Wan X; Shahzad KA; Pei W; Zhao C; Shen C
    Cancer Immunol Res; 2019 Jul; 7(7):1188-1201. PubMed ID: 31113806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens.
    Litton MJ; Dohlsten M; Rosendahl A; Ohlsson L; Søgaard M; Andersson J; Andersson U
    Br J Cancer; 1999 Sep; 81(2):359-66. PubMed ID: 10496366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of cytolytic CD8+ T cells in B16-melanoma and proliferation of mature T cells in TIS21-knockout mice after T cell receptor stimulation.
    Ryu MS; Woo MY; Kwon D; Hong AE; Song KY; Park S; Lim IK
    Exp Cell Res; 2014 Oct; 327(2):209-21. PubMed ID: 25088256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a novel IL-15 based protein with improved developability and efficacy for cancer immunotherapy.
    Hu Q; Ye X; Qu X; Cui D; Zhang L; Xu Z; Wan H; Zhang L; Tao W
    Sci Rep; 2018 May; 8(1):7675. PubMed ID: 29769573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol Esterification Enzyme Inhibition Enhances Antitumor Effects of Human Chimeric Antigen Receptors Modified T Cells.
    Zhao L; Li J; Liu Y; Kang L; Chen H; Jin Y; Zhao F; Feng J; Fang C; Zhu B; Ding S; Yu L; Wei Y; Zhou J
    J Immunother; 2018; 41(2):45-52. PubMed ID: 29252915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
    Yin W; Song Y; Liu Q; Wu Y; He R
    Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acyl-coenzyme A: cholesterol acyltransferase inhibitor Avasimibe affect survival and proliferation of glioma tumor cell lines.
    Bemlih S; Poirier MD; El Andaloussi A
    Cancer Biol Ther; 2010 Jun; 9(12):1025-32. PubMed ID: 20404512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.